Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.30
-0.06 (-0.45%)
Jun 12, 2026, 4:00 PM EDT - Market closed

Dr. Reddy's Laboratories Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
11,16011,56011,00712,2409,4639,252
Market Cap Growth
-9.29%5.03%-10.08%29.35%2.27%-9.07%
Enterprise Value
11,08611,48410,92011,7458,8759,114
Last Close Price
13.3013.8513.1914.6811.3911.15
PE Ratio
24.4225.1816.6318.3117.2829.87
PS Ratio
3.123.222.893.663.163.28
PB Ratio
2.752.872.823.613.343.66
P/TBV Ratio
0.040.050.050.050.050.06
P/FCF Ratio
31.8132.3349.7135.1516.3552.23
P/OCF Ratio
18.4419.0420.2622.4613.2124.99
EV/Sales Ratio
3.093.202.873.512.973.23
EV/EBITDA Ratio
15.2519.2111.6413.2012.5819.34
EV/EBIT Ratio
21.1130.4214.7916.5016.0928.88
EV/FCF Ratio
31.6032.1249.3233.7315.3451.44
Debt / Equity Ratio
0.190.190.140.070.050.17
Debt / EBITDA Ratio
-1.380.580.270.230.95
Debt / FCF Ratio
1.612.312.470.690.282.52
Net Debt / Equity Ratio
-0.03-0.03-0.03-0.15-0.21-0.05
Net Debt / EBITDA Ratio
0.09-0.19-0.14-0.56-0.83-0.29
Net Debt / FCF Ratio
-0.22-0.31-0.59-1.42-1.02-0.78
Asset Turnover
0.590.630.740.780.790.76
Inventory Turnover
2.042.152.012.062.141.86
Quick Ratio
1.131.131.141.481.571.14
Current Ratio
1.801.801.922.592.381.82
Return on Equity (ROE)
11.23%11.84%18.47%21.61%21.21%12.91%
Return on Assets (ROA)
-17.80%4.72%10.48%12.68%10.91%6.21%
Return on Invested Capital (ROIC)
-22.65%5.90%13.18%16.72%14.44%7.99%
Return on Capital Employed (ROCE)
-32.30%9.12%19.27%22.39%20.75%12.54%
Earnings Yield
4.09%3.97%6.01%5.46%5.79%3.35%
FCF Yield
3.14%3.09%2.01%2.84%6.11%1.91%
Dividend Yield
0.54%0.62%0.71%0.65%0.64%0.59%
Payout Ratio
13.04%15.54%11.78%11.94%11.05%17.59%
Buyback Yield / Dilution
0.10%0.10%-0.08%-0.19%-0.03%-0.01%
Total Shareholder Return
0.64%0.72%0.63%0.46%0.61%0.58%
SEC Filings: 10-K · 10-Q